Nigeria CDC/Nigeria Field Epidemiology and Laboratory Training Programme 2^nd Annual Scientific Conference (Abuja, 2017)

Factors influencing partner disclosure of HIV seropositive status among women attending ante-retroviral clinics in Osun State, Nigeria, 2016

Pan African Medical Journal - Conference Proceedings. 2018:8(15).21 Mar 2018.
doi: 10.11604/pamj-cp.2018.8.15.597

Archived on: 21 Mar 2018

Contact the corresponding author

Keywords: HIV, sero-positivity, partner, disclosure

Opening ceremony

---

Factors influencing partner disclosure of HIV seropositive status among women attending ante-retroviral clinics in Osun State, Nigeria, 2016

Oluwatoyin Adeola-Musa^1,2,&, Olufunmilayo Fawole³, Babatunde Adedokun³, Abiodun Egwuenu⁴, Patrick Nguku¹

¹Nigeria Field Epidemiology and Laboratory Training Programme, Abuja, Nigeria, ²Epidemiology Division, Osun State Ministry of Health, Nigeria, ³Department of Epidemiology and Medical statistics, College of Medicine, University of Ibadan, Nigeria, ⁴Nigeria Center for Disease Control, Abuja, Nigeria

^&Corresponding author
Oluwatoyin Adeola-Musa, Nigeria Field Epidemiology and Laboratory Training Programme, Epidemiology Division, Osun State Ministry of Health, Abuja, Nigeria

Abstract

Introduction: disclosure of Human immunodeficiency virus (HIV) sero-status is reportedly low in low-income countries especially among women. Pregnant women require special support to reduce the risk of mother-to-child transmission and to adopt effective management strategies. We compared the disclosure status and factors affecting willingness for disclosure in pregnant and non-pregnant women in Osun State, South-West Nigeria.

Methods: we conducted a comparative cross-sectional survey of 235 pregnant and non-pregnant women each from Anti-Retroviral Clinics in Osun State, Nigeria. We selected respondents from private and public facilities; with secondary and tertiary facilities selected from the public owned facilities in September 2016 using a two-stage sampling technique. We collected data with a pretested semi-structured questionnaire. We analyzed data with chi-square and logistic regression set at significance cut-off of p < 0.05.

Results: HIV status disclosure was 84.3% (198) among pregnant compared with 60.0% (141) in non-pregnant respondents (p < 0.001). On bivariate analysis there was association (p < 0.05) between disclosure status and type of marriage, length of relationship, level of education, number of children, been accompanied by spouses, pre-test counselling and social support. Independent predictors of HIV disclosure among pregnant women were: informing spouses before HIV test, (adjusted odds ratio (AOR): 11.6, 95% CI: 2.2 - 61.0) and awareness of partner’s HIV status (AOR: 18.2; 95% CI: 3.8-86.5). In non-pregnant women, predictors of disclosure were: being currently married (AOR: 3.7, 95% CI: 1.4-9.6), monogamous marriage (AOR: 3.6, 95% CI: 1.4 - 9.5), receipt of pre-test counselling (AOR: 9.4, 95% CI: 1.1-78.1) and awareness of partner’s HIV status (AOR: 26.0, 95% CI 9.6-70.4).

Conclusion: disclosure of HIV seropositive status was higher among pregnant women compared to non-pregnant women due to attention placed on prevention of mother-to-child transmission of HIV. Information, Education and Communication materials on the need to disclose HIV status were provided to respondents. We recommend more intense health education campaign, couple counselling and involvement of partners in patients’ care.